Skip to content

Comparison of clinical efficacy between ELIF and PLIF/TLIF/MIS-TLIF in the treatment of single-segment degenerative diseases

Comparison of clinical efficacy between ELIF and PLIF/TLIF/MIS-TLIF in the treatment of single-segment degenerative diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040383
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Lumbar Spondylolisthesis

Interventions

posterior lumbar interbody fusion group:posterior lumbar interbody fusion
transforaminal lumbar interbody fusion group:transforaminal lumbar interbody fusion
minimally invasive surgery-transforaminal lumbar interbody fusion group:minimally invasive surgery-transforaminal lumbar interbody fusion

Sponsors

Department of Spinal Orthopaedics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 40 to 80 years; 2. The patients with single-segment lumbar degenerative disease had corresponding manifestations of spinal canal stenosis or spondylolisthesis, including lumbar pain, radiation pain, intermittent claudication, sensory abnormality, motor dysfunction and reflex abnormality; 3. With conservative treatment ineffective for more than 3 months; 4. Imaging showed stenosis of spinal canal and spondylolisthesis of lumbar vertebrae I - II degree; 5. The clinical symptoms and signs are consistent with the imaging findings; 6. The severity of the disease reached the standard of surgical treatment; 7. No history of lumbar trauma or surgery.

Exclusion criteria

Exclusion criteria: 1. There are degenerative lesions in multiple lumbar segments; 2. Lumbar spinal stenosis caused by other spinal diseases, such as ankylosing spondylitis and spinal tumors; 3. Complicated with other spinal diseases, such as spinal tumors, spinal infections, spinal deformities, etc.' 4. There are other lesions that may cause low back pain and lower limb dysfunction, such as burst fracture of vertebral body, intermittent claudication caused by arterial embolism of lower extremities, cerebrovascular accident, etc.; 5. Serious medical diseases and metabolic diseases such as severe cardiopulmonary insufficiency or severe osteoporosis; 6. Severe osteoarthritis or rheumatoid arthritis, resulting in joint dysfunction of the lower extremities; 7. Neurological or mental disorders, such as dementia, stroke, etc., in which informed consent cannot be given; 8. After total hip or knee arthroplasty; 9. There are recent muscle injury and its possibility.

Design outcomes

Primary

MeasureTime frame
Oswestry Disability Index;Japanese Orthopaedic Association Scores;Visual analogue scale of low back pain;Visual analogue scale of lower extremity pain;The height of the intervertebral space at the lesion segment;creatine kinase(CK);Cross-sectional area of paraspinal muscle;Fat infiltration of paraspinal muscle;Hyperemia degree of paraspinal muscle;

Countries

China

Contacts

Public ContactJiang Xiaobing

Guangzhou University of Chinese Medicine

spinedrjxb@sina.com+86 13632494486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026